atorvastatin has been researched along with gadolinium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aikawa, E; Chen, JW; Figueiredo, JL; Libby, P; Nahrendorf, M; Panizzi, P; Sosnovik, D; Swirski, FK; Weissleder, R | 1 |
| Aktas, O; Bellmann-Strobl, J; Dörr, J; Haertle, M; Paul, F; Volk, HD; Waiczies, H; Waiczies, S; Wernecke, KD; Wuerfel, J; Zipp, F | 1 |
| Bar-Or, A; Calabresi, PA; Cohen, JA; Cross, A; Ding, L; Goodman, A; Iklé, D; Kachuck, N; Kita, M; Kopetskie, H; Mass, M; Miller, A; Mokhtarani, M; Murphy, S; Pelletier, D; Preiningerova, J; Racke, M; Rosenberg, E; Schwid, S; Spencer, C; Stüve, O; Vollmer, T; Waubant, E; Weinstock-Guttman, B; Zamvil, SS | 1 |
2 trial(s) available for atorvastatin and gadolinium
| Article | Year |
|---|---|
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis.
Topics: Adjuvants, Immunologic; Administration, Oral; Atorvastatin; Gadolinium; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon-beta; Interleukins; Magnetic Resonance Imaging; Models, Biological; Multiple Sclerosis, Relapsing-Remitting; Multivariate Analysis; Pyrroles; Recurrence; Treatment Outcome | 2008 |
Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Brain; Canada; Confounding Factors, Epidemiologic; Contrast Media; Double-Blind Method; Female; Gadolinium; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Middle Aged; Odds Ratio; Pyrroles; Research Design; Syndrome; Treatment Outcome; United States | 2012 |
1 other study(ies) available for atorvastatin and gadolinium
| Article | Year |
|---|---|
Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Atorvastatin; Gadolinium; Heptanoic Acids; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Reperfusion Injury; Peroxidase; Pyrroles | 2008 |